Menopausal Symptoms in Women With Breast Cancer or At High Risk of Breast Cancer Treated on Another Clinical Trial
NCT00666913 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 183
Last updated 2015-09-29
Summary
RATIONALE: Gathering information about the frequency and intensity of hot flashes in patients with breast cancer and in patients who have a high risk of developing breast cancer may help doctors learn more about menopausal symptoms.
PURPOSE: This clinical trial is looking at menopausal symptoms in women with breast cancer or at high risk of breast cancer who received treatment on another clinical trial.
Conditions
Interventions
- OTHER
-
informational intervention
Data from an archived database of a closed clinical trial is retrieved.
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH -
Case Comprehensive Cancer Center
lead OTHER
Principal Investigators
-
Lois C. Friedman, PhD · Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-10-31
- Primary Completion
- 2010-06-30
- Completion
- 2010-06-30
Countries
- United States
Study Locations
More Related Trials
-
Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer
NCT00060320 ·Status: COMPLETED ·Phase: PHASE3
-
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
NCT00068601 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy Decisions and Outcomes in Older Women With Newly Diagnosed Breast Cancer
NCT00068328 ·Status: COMPLETED
-
Drug Withdrawal in Women With Progressive Breast Cancer While on Aromatase Inhibitor Therapy
NCT00916162 ·Status: COMPLETED
-
Writing Interventions in Breast Cancer Patients Taking Aromatase Inhibitors
NCT04651452 ·Status: COMPLETED ·Phase: NA
-
Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
NCT00427245 ·Status: COMPLETED ·Phase: PHASE3
-
SWOG-8814 Tamoxifen With or Without Combination Chemotherapy in Postmenopausal Women Who Have Undergone Surgery for Breast Cancer
NCT00929591 ·Status: COMPLETED ·Phase: PHASE3
-
Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer
NCT00005605 ·Status: COMPLETED
-
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
NCT00002580 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
NCT00002646 ·Status: COMPLETED ·Phase: PHASE3
-
Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
NCT00066690 ·Status: COMPLETED ·Phase: PHASE3
-
Tamoxifen Pharmacogenetics and Clinical Effects
NCT00228930 ·Status: COMPLETED
-
A Study to Prevent and Improve Sexual Health Concerns for People With Breast Cancer
NCT05910294 ·Status: RECRUITING ·Phase: NA
-
Afimoxifene in Reducing the Risk of Breast Cancer in Women With Mammographically Dense Breast
NCT03063619 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
NCT00238316 ·Status: COMPLETED ·Phase: PHASE2
-
Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer
NCT00031850 ·Status: COMPLETED ·Phase: NA
-
Effect of Tamoxifen on Breast Density in Premenopausal Women With Breast Cancer or High Risk for Breast Cancer
NCT00086749 ·Status: COMPLETED
-
Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast Cancer
NCT00002529 ·Status: COMPLETED ·Phase: PHASE3
-
St. John's Wort in Relieving Hot Flashes in Postmenopausal Women With Non-Metastatic Breast Cancer
NCT00110136 ·Status: TERMINATED ·Phase: PHASE2
-
AMH Predicts Postchemotherapy Menopause in Premenopausal Breast Cancer Patients
NCT06313476 ·Status: NOT_YET_RECRUITING
-
Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer
NCT00280930 ·Status: UNKNOWN ·Phase: PHASE2
-
Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients
NCT02132000 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Examination of Breast Cancer Cells of Pre-menopausal and Post-menopausal Women Before and After Exposure to Tamoxifen or Fulvestrant.
NCT02936206 ·Status: TERMINATED ·Phase: PHASE1
-
Anastrozole and ZD1839 Compared With Fulvestrant and ZD1839 in Postmenopausal Women w/ Metastatic Breast Cancer
NCT00057941 ·Status: COMPLETED ·Phase: PHASE2
-
FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in Women With Breast Cancer on Endocrine Therapy
NCT06917313 ·Status: RECRUITING ·Phase: PHASE2